# Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography

Study · id `cardio:ct-nct01255722` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01255722](<https://clinicaltrials.gov/study/NCT01255722>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01255722

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 468 participants.

## Technical summary

Registry record NCT01255722. Randomized; double masking; primary purpose diagnostic. Start 2010-11 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2015-12-16.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose diagnostic
- Phase: Phase 4
- Enrolled: 468 participants (enrolled count; ClinicalTrials.gov record NCT01255722, source copy `cardio:ctgov-nct01255722-2015-12-16`, retrieved 2026-10-26)
- Start date: 2010-11 (registry gives no type) (ClinicalTrials.gov record NCT01255722, source copy `cardio:ctgov-nct01255722-2015-12-16`, retrieved 2026-10-26)
- Primary completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01255722, source copy `cardio:ctgov-nct01255722-2015-12-16`, retrieved 2026-10-26)
- Completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01255722, source copy `cardio:ctgov-nct01255722-2015-12-16`, retrieved 2026-10-26)
- Results first posted: 2015-12-16 (ClinicalTrials.gov record NCT01255722, source copy `cardio:ctgov-nct01255722-2015-12-16`, retrieved 2026-10-26)
- Countries: France; Germany; Italy; Spain; Switzerland (ClinicalTrials.gov record NCT01255722, source copy `cardio:ctgov-nct01255722-2015-12-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01255722-2015-12-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography
- Acronym: X-ACT
- Condition: Coronary Artery Disease
- Intervention (Drug): iobitridol
- Intervention (Drug): iopromide
- Intervention (Drug): iomeprol
- Lead sponsor: Guerbet
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Guerbet (`cardio:org-guerbet`)

## Provenance

Content hash: b19154d8d536e3cf35c8438af125153197e770df868a3cfea4392966836528cf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
